• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

by Fred Pennic 04/30/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– French deeptech startup Chipiron today announced it has raised $17M in a Series A funding round to finalize the development of its compact, affordable MRI system. 

– Led by Blast, with participation from the EIC Fund and iXcore, and supported by public funding initiatives including France2030 and the EIC Accelerator, the investment aims to make highly accurate MRI technology accessible worldwide.

Tackling MRI Accessibility Challenges

Magnetic Resonance Imaging (MRI) is widely regarded as the most precise medical imaging modality available, yet its use remains limited. Traditional MRI systems are large, extremely expensive, and require complex hospital infrastructure, restricting their deployment primarily to major hospitals. This lack of accessibility contributes to disparities in diagnostic capabilities and patient care. The global MRI market, estimated at $10B, has the potential to double if the technology becomes more widely available.

Founded in 2020 by CEO Evan Kervella and CSO Dimitri Labat, Chipiron aims to make MRI as accessible as an X-ray. The company is developing a next-generation, ultra-low-field MRI machine that is designed to be as reliable as current models but significantly more compact, mobile, and affordable – potentially 10 times less expensive than current standards. This breakthrough design opens up possibilities for deployment in facilities previously excluded from MRI use, such as local care centers, private clinics, and mobile units. Furthermore, the smaller size makes MRI scans feasible for patients often excluded from traditional machines, including those with pacemakers or implants, claustrophobic individuals, obese or elderly patients, and restless children.

Expansion Plans

The company plans to produce its first clinical prototypes by the end of 2025 and commence investigational trials in hospital settings starting in 2026. Looking ahead three to five years, Chipiron has clear objectives: achieve an initial clinical application, secure the first FDA (US) and CE (Europe) regulatory authorizations, and deploy 100 commercial devices. The company plans a significant focus on expanding into the extensive US healthcare market, known for its adoption of innovative solutions, with the ultimate goal of establishing a new global standard in accessible medical imaging.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: radiology

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |